Bausch & Lomb (BLCO) Long-Term Deferred Tax (2021 - 2026)
Bausch & Lomb's (BLCO) quarterly Long-Term Deferred Tax came in at $952.0 million in Q2 2026, down 2.16% YoY from $973.0 million in Q2 2025, and up 0.74% on a QoQ basis from $945.0 million in Q1 2026.
Bausch & Lomb (BLCO) Long-Term Deferred Tax (2021 - 2026) Analysis & Trends
Bausch & Lomb (BLCO) has 6 years of Long-Term Deferred Tax data on file, last reported at $952.0 million in Q2 2026.
- Quarterly Long-Term Deferred Tax fell 2.16% year-over-year to $952.0 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $952.0 million (down 2.16% YoY) and the FY2025 annual result came in at $934.0 million, up 5.54% from the prior year.
- Long-Term Deferred Tax advanced to $952.0 million in Q2 2026, from $945.0 million in the prior quarter.
- In the past five years, Long-Term Deferred Tax ranged from a high of $1.0 billion in Q1 2022 to a low of $827.0 million in Q2 2024.
- A 5-year average of $923.3 million and a median of $925.0 million in 2022 frame the typical range for Long-Term Deferred Tax.
- Annual changes were most pronounced in 2024 — Long-Term Deferred Tax retreated 11.83% — and 2025, when it increased 17.65%.
- Tracing BLCO's Long-Term Deferred Tax over 5 years: stood at $927.0 million in 2022, then decreased by 0.65% to $921.0 million in 2023, then retreated by 3.91% to $885.0 million in 2024, then grew by 5.54% to $934.0 million in 2025, then grew by 1.93% to $952.0 million in 2026.
- The last three Long-Term Deferred Tax figures came in at $952.0 million (Q2 2026), $945.0 million (Q1 2026), and $934.0 million (Q4 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn |
| 10 | Bausch & Lomb | 6.14 Bn | 5.76 Bn | 867.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 952.00 Mn |
| Mar 31, 2026 | 945.00 Mn |
| Dec 31, 2025 | 934.00 Mn |
| Sep 30, 2025 | 978.00 Mn |
| Jun 30, 2025 | 973.00 Mn |
| Mar 31, 2025 | 864.00 Mn |
| Dec 31, 2024 | 885.00 Mn |
| Sep 30, 2024 | 931.00 Mn |
| Jun 30, 2024 | 827.00 Mn |
| Mar 31, 2024 | 860.00 Mn |
| Dec 31, 2023 | 921.00 Mn |
| Sep 30, 2023 | 920.00 Mn |
| Jun 30, 2023 | 938.00 Mn |
| Mar 31, 2023 | 923.00 Mn |
| Dec 31, 2022 | 927.00 Mn |
| Sep 30, 2022 | 904.00 Mn |
| Jun 30, 2022 | 912.00 Mn |
| Mar 31, 2022 | 1.03 Bn |
| Dec 31, 2021 | 933.00 Mn |